O. Legrand

435 total citations
7 papers, 212 citations indexed

About

O. Legrand is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, O. Legrand has authored 7 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in O. Legrand's work include Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and Retinoids in leukemia and cellular processes (2 papers). O. Legrand is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and Retinoids in leukemia and cellular processes (2 papers). O. Legrand collaborates with scholars based in France, United States and Italy. O. Legrand's co-authors include Ghislaine Simonin, R Zittoun, Philippe Rousselot, J. P. Marie, Anne Vekhoff, F. Chast, Christophe Bardin, Gabrielle Roth-Guépin, Simona Zompì and Florent Malard and has published in prestigious journals such as British Journal of Cancer, British Journal of Haematology and Leukemia.

In The Last Decade

O. Legrand

7 papers receiving 206 citations

Peers

Countries citing papers authored by O. Legrand

Since Specialization

Citations

This map shows the geographic impact of O. Legrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Legrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Legrand more than expected).

Fields of papers citing papers by O. Legrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Legrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Legrand. The network helps show where O. Legrand may publish in the future.

Co-authorship network of co-authors of O. Legrand

This figure shows the co-authorship network connecting the top 25 collaborators of O. Legrand. A scholar is included among the top collaborators of O. Legrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Legrand. O. Legrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients 2015 ·Transplant Infectious Disease ·Annalisa Ruggeri, Gabrielle Roth-Guépin, Giorgia Battipaglia, (unknown), Florent Malard, Alberto Gómez, Éolia Brissot, (unknown), Anne Vekhoff, Simona Lapusan, F Isnard, O. Legrand, Joël Gozlan, David Boutolleau, Tounes Ledraa, Myriam Labopin, (unknown), Mohamad Mohty	54
2	A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study 2010 ·Haematologica ·Mathilde Hunault, (unknown), Xavier Thomas, O. Legrand, Françoise Huguet, Caroline Bonmati, Martine Escoffre‐Barbe, Laurence Legros, Pascal Turlure, Patrice Chevallier, Fabrice Larosa, Frédéric Garban, Oumédaly Reman, Philippe Rousselot, Nathalie Dhédin, André Delannoy, Mårina Lafage‐Pochitaloff, Marie C. Béné, Norbert Ifrah, Hervé Dombret	49
3	A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia 2006 ·British Journal of Cancer ·Vincent Lévy, Sarah Zohar, Christophe Bardin, Anne Vekhoff, Driss Chaoui, Bernard Rio, O. Legrand, (unknown), Philippe Rousselot, Emmanuel Raffoux, F. Chast, Sylvie Chevret, J. P. Marie	44
4	Therapy‐related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature 2000 ·British Journal of Haematology ·Simona Zompì, O. Legrand, Didier Bouscary, (unknown), Françoise Picard, Nicole Casadevall, F. Dreyfus, J. P. Marie, F Viguié	25
5	Smoldering Acute Myelogenous Leukemia in the Elderly 1999 ·Leukemia & lymphoma ·Marion Baudard, O. Legrand, (unknown), R Zittoun	7
6	Lung resistance protein (LRP) gene expression in adult acute myeloid leukemia: a critical evaluation by three techniques 1998 ·Leukemia ·O. Legrand, Ghislaine Simonin, R Zittoun, (unknown)	31
7	CEFTAZIDIME : AVANTAGES DES PERFUSIONS CONTINUES CHEZ UN MALADE EN APLASIE 1993 ·La Presse Médicale ·O. Legrand, (unknown), Christophe Bardin, Yvonnick Bézie, (unknown), (unknown), F. Chast, R Zittoun	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact